Today: 21 May 2026
Browse Category

NASDAQ:SCNX 16 October 2025 - 24 October 2025

Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next?

Scienture (NASDAQ: SCNX) soared 355% to close near $2.60 on Oct. 23, 2025, after announcing the launch of Arbli, the first FDA-approved liquid losartan. Shares fell about 25% after hours and swung between $0.83 and $2.60 on Oct. 24. The company secured distribution deals covering over 100 million patients and converted all convertible debt to equity earlier in October. Analyst coverage remains sparse, with a consensus “Sell” rating.
24 October 2025
·
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Holdings (NASDAQ: SCNX) jumped up to 45% in pre-market trading on Oct. 23, 2025, after announcing its first commercial sales of Arbli, the only FDA-approved ready-to-use liquid losartan. Trading volume surged to 77 million shares, far above its 4 million average. Despite the spike, SCNX remains down over 90% for the year. The company recently eliminated all debt by converting debentures to equity.
23 October 2025
··
Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

SCNX shares jumped over 30% in early trading Oct. 16 after Scienture announced Arbli, the first FDA-approved ready-to-use liquid losartan, is now available through major wholesalers. The stock hit an intraday high of $1.12 before trading near $0.71 by mid-day. Scienture recently secured a major rebate deal to drive Arbli’s adoption. Analysts remain cautious, citing weak financials and high volatility.
16 October 2025
··

Stock Market Today

  • Burlington Stores (BURL) Shares Surge 8.4% Amid Strong Retail Performance
    May 21, 2026, 8:15 AM EDT. Burlington Stores (BURL) shares jumped 8.4% to $310.19, rebounding from a 16.3% decline over four weeks. The off-price retailer is expanding via improved assortments, supply-chain efficiencies, and aggressive store growth. Analysts expect Burlington's quarterly earnings per share (EPS) to rise 8.1% to $1.73, with revenue up 11.6% at $2.79 billion. Despite positive sales momentum, recent earnings estimate revisions have been modestly downward by 0.9%, tempering immediate upside expectations. Burlington holds a Zacks Rank #2 (Buy). Comparatively, Costco (COST) in the same sector closed 1.9% lower, with a 14.7% rise in EPS estimates and a Zacks Rank #3 (Hold). Investors should monitor earnings guidance for further direction.

Latest articles

JetBlue Is Cutting 11 Routes. Fort Lauderdale Is Why.

JetBlue Is Cutting 11 Routes. Fort Lauderdale Is Why.

21 May 2026
JetBlue Airways will cut 11 routes this summer, including a full exit from Manchester-Boston Regional Airport, as it shifts planes to Fort Lauderdale following Spirit Airlines’ shutdown. Affected Manchester flights end July 8. JetBlue plans to add 11 destinations and increase daily departures from Fort Lauderdale by over 75% compared to 2025. The airline reported a $319 million first-quarter loss and cited volatile fuel prices.
NIO Stock Rises Before Onvo L80 Launch as China EV Demand Faces a Hard Test

Nio slips to red, but margin draws investor attention

21 May 2026
Nio reported first-quarter revenue up 112.2% to RMB25.53 billion ($3.70 billion) and vehicle margin rising to 18.8%. The company posted a net loss of RMB332.1 million, compared to a profit in the previous quarter. Deliveries reached 83,465 vehicles, nearly doubling from a year earlier but down from the fourth quarter. Nio forecast second-quarter revenue and deliveries above analyst expectations.
IBM Stock Tumbles After Earnings Beat as Software Slowdown Reignites AI Fears

IBM, Rigetti, D-Wave gain after $2B quantum investment from Washington

21 May 2026
The Commerce Department will provide $2.013 billion in CHIPS Act incentives to nine quantum computing companies, taking minority, non-controlling equity stakes in each. IBM will receive $1 billion to establish a quantum foundry subsidiary, while GlobalFoundries gets $375 million. Shares of several quantum firms rose sharply in premarket trading following the announcement.
Go toTop